Group Psychotherapy for People With HIV

This study has been completed.
Sponsor:
Collaborator:
Stanford University
Information provided by:
National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier:
NCT00186550
First received: September 13, 2005
Last updated: February 29, 2008
Last verified: February 2008
  Purpose

This study will examine the effectiveness of supportive-expressive group therapy plus education compared with an educational intervention in improving the quality of life and promoting health-enhancing behavior of men and women living with HIV or AIDS.


Condition Intervention Phase
HIV
Depression
Risk-Taking
Pain
Behavioral: Supportive Expressive Group Psychotherapy
Behavioral: Education
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Evaluation of Group Psychotherapy for People With HIV

Resource links provided by NLM:


Further study details as provided by National Institute of Mental Health (NIMH):

Study Completion Date: November 2000
Detailed Description:

The major goal of this project is to examine the effectiveness of supportive-expressive group therapy plus education in comparison to an educationally intervention in improving the quality of life and promoting health-enhancing behavior of men and women living with HIV/AIDS.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 1) a positive HIV diagnosis (either symptomatic or asymptomatic), 2) at least eighteen years of age, 3) English language skill (to complete questionnaires and participate, if assigned, to the group psychotherapy condition) and, 4) geographical proximity to groups in order to attend if assigned.

Exclusion Criteria:

  • 1) severe psychiatric disorders (i.e. schizophrenia or other psychotic disorders)who would not be appropriate for participating in the group intervention, 2) active tuberculosis, 3) acute intoxication, 4) participation in an ongoing HIV/AIDS support group or 5) suicidal/homicidal ideation.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00186550

Locations
United States, California
Stanford University
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: David Spiegel, M.D. Stanford University
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00186550     History of Changes
Other Study ID Numbers: MH54930
Study First Received: September 13, 2005
Last Updated: February 29, 2008
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 23, 2013